Sat.Dec 11, 2021 - Fri.Dec 17, 2021

CAR-T therapy trials show promise for earlier use in lymphoma

Bio Pharma Dive

Study results presented at ASH suggest Gilead's Yescarta and Bristol Myers Squibb's Breyanzi could become replacements for stem cell transplants in treating the blood cancer

Trials 271

An app can never replace a doctor

World of DTC Marketing

The concept that a medical app can replace a health care professional is myopic. At best, health apps can alert users to potential problems, but only a trained health care professional can diagnose problems.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biologic Therapeutics Development, Part 2: Regulatory Pathways and Pharmacometric Analysis


The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available.

Now scientists can efficiently screen billions of chemical compounds to find effective new drug therapies


Key takeaways: Credit: USC Dornsife/Yekaterina Kadyshevskaya Key takeaways: New technology called “V-SYNTHES” uncovers more effective drug candidates in a fraction of the time other algorithms need. The method screens virtual chemical components that can be “clicked” together to build a drug.

Lessons in Supply Chain Digitization from PepsiCo and Conagra

Speaker: Craig Weiss, ConAgra Brands; Mari Roberts PepsiCo; and Matt Elenjickal, FourKites

Supply chain digitalization is key to success as market volatility, widespread disruption & stiff competition for consumer dollars puts pressure on every aspect of the supply chain. Register to hear how 2 global brands are accelerating digital transformation and increasing efficiency & automation throughout their operations.

J&J's coronavirus vaccine faces new US limits

Bio Pharma Dive

Days after the FDA strengthened safety warnings for the company's shot, a CDC panel recommended Pfizer's and Moderna's vaccines be "preferred" over J&J's

Pharma’s big lie is about greed

World of DTC Marketing

The public has been told that pharma needs money to develop new drugs, but unfortunately, that’s a huge lie.

Sales 182

More Trending

Citrus greening disease can infect an entire tree weeks before symptoms appear


For the first time ever, scientists have been able to measure the speed of a bacterium that causes the incurable citrus greening disease. Citrus greening disease (also known as Huanglongbing) is the most devastating citrus disease in the world.

Rebounding from setbacks, Sanofi reveals promising data for hemophilia drug

Bio Pharma Dive

Fitusiran, which Sanofi licensed from Alnylam, could finally get to market after trial delays and safety concerns slowed its progress. But gene therapies and other new medicines might provide competition

Pharma industry making record profits

World of DTC Marketing

(Axios) Second-quarter results are still pouring in, but so far, a vast majority of health care companies are reporting profits that many people assumed would not have been possible as the pandemic continued.

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Big pharma has compelling reasons to change the way business gets done. The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size.

3 Ways End-to-End Visibility Helps Minimize the Risks of Ocean Freight

Download this playbook to learn how end-to-end visibility helps to mitigate risk associated with the ocean freight market.

Impact of HIV virus on COVID-19 disease


A new study found that during the early months of the COVID-19 pandemic people living with HIV were less likely to die from COVID than persons without HIV.

Two cancer cell therapy studies succeeded. Why did a third fail?

Bio Pharma Dive

Novartis' CAR-T drug Kymriah didn't appear better than standard of care in earlier lymphoma treatment. Its two similar rivals, Gilead's Yescarta and Bristol Myers' Breyanzi, did, raising questions about potential differences

Drugs 262

Insulin prices demonstrate pharma’s greed

World of DTC Marketing

WHAT’S HAPPENING: In the Build Back Better bill , Democrats are actually proposing limiting insulin prices to $35 a month but Republicans can’t have any of that. PhRMA spent pharma’s money well and bought some politicians while people who need insulin are suffering.

Panel discussion at Clinical Monitoring and Patient Recruitment (CMPRR)


The post Panel discussion at Clinical Monitoring and Patient Recruitment (CMPRR) appeared first on Clinical Trial Recruitment & Management Services.

4 Silver Linings of the Chaotic Ocean Freight Market

Speaker: Peter Tirschwell, Chris Stauber, Sarah Barnes Humphrey, and Audrey Ross

Join this webinar exploring the silver linings that have emerged from the chaotic ocean freight market. The discussion will highlight solutions that prioritize digitization and build a more efficient international supply chain. Jan 25 at 10am CT.

Heart disease-protective diabetes drug not used equitably, study finds


A medication typically used for treating diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RA), could also be used to prevent cardiovascular disease and major cardiovascular events, but a new study showed inequities in its use based on race, ethnicity, and socioeconomic status.

Drugs 87

Bristol Myers returns to Immatics for a dual-targeting cancer drug

Bio Pharma Dive

The pharma has expanded an alliance with a German biotech by paying $150 million for a drug candidate that executives hope can have "cell therapy-like efficacy" for solid tumors

Drugs 257

Tips for Getting Your Insurance Company to Cover Breast Explant Surgery

Triage Cancer

Getting breast implants can change a person’s life for the better. According to the American Society of Plastic Surgeons and the Plastic Surgeon Foundation, approximately 10 million to 11 million women in the world have breast implants.

Clinical trials: 2021 Recap and take-aways for 2022 and ahead. From Vaccine trials, new regulations, decentralized trials and patient-centricity


The post Clinical trials: 2021 Recap and take-aways for 2022 and ahead. From Vaccine trials, new regulations, decentralized trials and patient-centricity appeared first on Clinical Trial Recruitment & Management Services.

The Smart Data Revolution: How AB InBev Drives Efficiency with Visibility Data

Speaker: AB InBev and FourKites

Register for our upcoming webinar to learn how leveraging the right data to make quick, well-informed decisions is the key to success in supply chain & logistics. Join FourKites and AB InBev to learn what’s possible with a data-driven supply chain strategy & real-time transportation visibility.

Diverse plant water-use strategies make forests more resilient to extreme drought


Flush with cash, large drugmakers turn to share buybacks, deals

Bio Pharma Dive

Novartis is using funds gained from the recent sale of its stake in Roche to buy back $15 billion worth of its own shares, while Pfizer is signaling more dealmaking could follow its buyout of Arena

Sales 249

Judge Overturns Purdue Pharma’s Opioids Settlement

NY Times

The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.

Drugs 114

From patient engagement to patient centricity

Pharma Phorum

Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. But the difference between them is not like the choice between “agreeing” and “aligning” or “getting together later” and “taking this offline.”

Modernizing Pharmaceutical Supply Chains

Speaker: Nimesh Patel, Gregory Demitrack, and Sarah Barnes Humphrey

Register for our upcoming webinar to better understand the state of the pharmaceutical supply chain. FourKites partnered with Accenture to survey supply chain executives working in pharmaceuticals, biotech, cell and gene therapy, medtech, and other related industries.

Cancer-spotting AI and human experts can be fooled by image-tampering attacks


PITTSBURGH, Dec. 14, 2021 – Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve accuracy of cancer diagnoses, but they may also be vulnerable to cyberattacks.

In final analysis, Pfizer's COVID-19 pill remains highly effective

Bio Pharma Dive

Full study results show Paxlovid cut the risk of COVID-19 hospitalization or death by about 90% among high-risk adults, matching the interim findings Pfizer disclosed last month


Firms Push for Over-the-Counter Access to Birth-Control Pills

NY Times

Two drugmakers have been mired for years in the pre-application phase of getting F.D.A. approval for over-the-counter use. Drugs (Pharmaceuticals) Birth Control and Family Planning Medicine and Health Food and Drug Administration HRA Pharma Cadence Health Inc

Pfizer buys immuno-inflammatory firm Arena Pharmaceuticals for $6.7b

Outsourcing Pharma

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions. Markets & Regulations

Minimizing Retail Supply Chain Disruptions in 2021 and Beyond

Speaker: Izaac Moran, Customer Success Manager, FourKites; Glenn Koepke, SVP of Customer Success, FourKites; and featuring interviews with supply chain experts from Dollar Tree and Best Buy

Register for our upcoming webinar to see how savvy retailers including Dollar Tree and Best Buy are leveraging real-time visibility across their end-to-end supply chains in creative ways to drive agility and thrive in today’s unpredictable environment.

Life arose on hydrogen energy


December 13, 2021 – How did the first chemical reactions get started at the origin of life and what was their source of energy? Researchers at the Heinrich Heine University Düsseldorf (HHU) have reconstructed the metabolism of the last universal common ancestor, LUCA.

EU regulator says member countries can use Pfizer's experimental COVID pill

Bio Pharma Dive

The European Medicines Agency is still reviewing Paxlovid but, citing fast increasing cases and deaths from COVID-19, offered flexibility to EU countries which may authorize emergency use

Merck’s Covid Pill Might Pose Risks for Pregnant Women

NY Times

Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.

DNA 109

Insilico Medicine launches trial for AI-discovered drug

Outsourcing Pharma

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis. Clinical Development

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.